Match each patient clinical profile with the most appropriate, guideline-concordant preventive care intervention or screening strategy.
- 42-year-old woman of Ashkenazi Jewish descent whose paternal grandmother had ovarian cancerAdministration of a brief familial risk assessment tool for genetic mutations
- 57-year-old asymptomatic man inquiring about routine screening for prostate cancerShared decision-making discussion regarding potential benefits and harms of testing
- 28-year-old sexually active man who has sex with men and reports multiple new partnersEvaluation for human immunodeficiency virus pre-exposure prophylaxis
- 33-year-old asymptomatic woman who recently immigrated from a tuberculosis-endemic countryTesting for latent infection using an interferon-gamma release assay
Cevap
The correct pairings appropriately match each patient's specific risk factors and demographic profile to current USPSTF preventive care guidelines: the Ashkenazi Jewish woman requires a BRCA risk assessment tool, the 57-year-old man requires shared decision-making for PSA screening, the high-risk man requires HIV PrEP evaluation, and the recent immigrant requires latent tuberculosis screening.
Each patient profile correctly maps to an evidence-based guideline tailored to their specific historical and demographic risk factors. The Ashkenazi Jewish patient meets criteria for a familial risk assessment tool due to heightened pre-test probability for BRCA mutations. The 57-year-old man falls into the age bracket (55-69 years) where PSA screening requires individualized shared decision-making. The 28-year-old man's sexual history indicates high risk for HIV, warranting PrEP evaluation. Finally, the 33-year-old woman's recent immigration from an endemic area is a classic trigger for latent tuberculosis screening.
Adım Adım Çözüm
Anahtar Kavram
Application of USPSTF and ACIP preventive care and screening guidelines based on patient-specific risk factors, age, and demographic characteristics.